G. Kelly Martin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for G. Kelly Martin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of G. Kelly Martin. G. Kelly Martin is Director in QUESTCOR PHARMACEUTICALS INC ($QSC) and CEO and President in Radius Health, Inc. ($RDUS) and Chief Executive Officer in Novan, Inc. ($NOVN) and Director in Novan, Inc. ($NOVN) and Interim Chief ExecutiveOfficer in Novan, Inc. ($NOVN).
Latest Insider Trading Transactions of G. Kelly Martin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NOVN, QSC, RDUS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | RDUS | Radius Health, Inc ... | Martin G. Kelly | CEO and President | Option Exercise | A | 28.60 | 460,000 | 13,156,000 | 460,000 | |
| Apr 29 2020 | RDUS | Radius Health, Inc ... | Martin G. Kelly | CEO and President | Option Exercise | A | 16.46 | 575,000 | 9,464,500 | 575,000 | |
| Aug 02 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Option Exercise | A | 3.80 | 1,000,000 | 3,800,000 | 1,000,000 | |
| May 30 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.97 | 1,500 | 2,955 | 45,000 | 43.5 K to 45 K (+3.45 %) |
| May 29 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 2.15 | 3,500 | 7,525 | 43,500 | 40 K to 43.5 K (+8.75 %) |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 40,000 | 57,200 | 40,000 | 0 to 40 K |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 40,000 | 57,200 | 40,000 | 0 to 40 K |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 20,000 | 28,600 | 60,000 | 40 K to 60 K (+50.00 %) |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 20,000 | 28,600 | 60,000 | 40 K to 60 K (+50.00 %) |
| Sep 27 2018 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 2.73 | 10,000 | 27,300 | 40,000 | 30 K to 40 K (+33.33 %) |
| Aug 23 2018 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 2.71 | 30,000 | 81,300 | 30,000 | 0 to 30 K |
| Jun 07 2017 | NOVN | Novan, Inc. | Martin G. Kelly | Interim Chief Execu ... | Option Exercise | A | 4.64 | 34,014 | 157,825 | 34,014 | |
| Sep 22 2016 | NOVN | Novan, Inc. | Martin G. Kelly | Director | Option Exercise | A | 11.00 | 14,484 | 159,324 | 14,484 | |
| Aug 18 2014 | QSC | QUESTCOR PHARMACEU ... | Martin G. Kelly | Director | Option Exercise | D | 61.60 | 1,160 | 71,454 | 0 | |
| Aug 18 2014 | QSC | QUESTCOR PHARMACEU ... | Martin G. Kelly | Director | Sell | D | 0.00 | 2,812 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
| Nov 13 2013 | QSC | QUESTCOR PHARMACEU ... | Martin G. Kelly | Director | Option Exercise | A | 61.60 | 6,187 | 381,107 | 6,187 | |
| Nov 13 2013 | QSC | QUESTCOR PHARMACEU ... | Martin G. Kelly | Director | Grant | A | 0.00 | 2,812 | 0 | 2,812 | 0 to 2.8 K |
Page: 1